marcus evans north america conferences

9th Pharma Resource Planning & Portfolio Management

Establishing Goals and Strategies to Optimize Portfolio Management and Drive Business Success

9-10 Mar 2016
Philadelphia Marriott Downtown - Philadelphia, PA, United States of America

Why You Should Attend

9th Pharma Resource Planning & Portfolio Management

Integrate reliable portfolio and resource management practices into your company. Via case study presentations, heads of portfolio management and resource planning will share their own success stories of how to maintain a competitive advantage in the complex global environment, while streamlining business operations.

Aligning strategic and operational portfolio management approaches is crucial for companies to meet the needs of the organization and optimize the portfolio. While addressing these issues, the two day conference takes the delegation beyond the traditional approaches to project and portfolio management and put them in touch with cutting edge strategies and methodologies that will prepare them to achieve a comprehensive and balanced portfolio.

Key Topics

  • Examine value-driven approaches behind portfolio management to drive return on investment
  • Implement a holistic resource management approach to drive decision making
  • Ensure optimal resource allocation to boost portfolio performance
  • Integrate forecasting metrics into portfolio management to ensure robust portfolios
  • Strengthen your portfolio through search and development and other external opportunities
  • Previous Attendees Include

    Baxter Healthcare Corporation, Biogen Idec, Eli Lilly, Gilead Sciences, Halozyme Therapeutics, Ipsen Biopharmaceuticals, Merck, Sanofi, Shire Human Genetic Therapies, Takeda Pharmaceuticals USA, Novartis Pharmaceuticals Corporation, Cubist Pharmaceuticals, Inc., EMD Serono, Inc., Pfizer, Inc., Johnson and Johnson, Amgen, and many more!

    Why Choose marcus evans?

    marcus evans specialises in the research and development of strategic events for senior business executives. From our international network of 63 offices, marcus evans produces over 1000 event days a year on strategic issues in corporate finance, telecommunications, technology, health, transportation, capital markets, human resources and business improvement.

    Above all, marcus evans provides clients with business information and knowledge which enables them to sustain a valuable competitive advantage and makes a positive contribution to their success.

    Event Sponsors
    Silver Sponsor
    Integrated Project Management, Inc.
    Visit website >>
    Silver Sponsor
    Visit website >>
    Silver Sponsor
    Decision Lens
    Visit website >>
    Silver Sponsor
    TayganPoint Consulting Group
    Visit website >>
    Panel Sponsor
    Visit website >>

    Event Partners

    Practical Insights From

    Dougal Beard
    Head of Capacity Planning and Resource Management
    GSK Consumer Healthcare R&D

    Jason Martucci, MS, MBA, LSSBB, PMP, RMP
    Director, Global R&D Project Management and Planning
    Alexion Pharmaceuticals

    Tom Defay
    Global Project Leader and Head of Informatics - Neuroscience iMed

    Jared Fantasia
    Head, Global Portfolio & Project Management Operations
    Johnson & Johnson Consumer Inc.

    Sam Mukherjee
    Associate Director, Portfolio Management
    Dr. Reddy's Laboratories, Inc.

    Diane Neiman
    Director, Global Project Management

    Eric Moss
    Director, Portfolio & Decision Analysis
    Pfizer, Inc.

    Click Here For Full Agenda

    Voice of Our Customers
    • "Nice focus on the key issues in portfolio management and resource planning straight from the mouths of the day to day practitioners. Salient and Succinct." Schering Plough
    • "The greatest benefit of marcus evans conferences is strong representation from industry and the time set aside for question and answer, panel discussions & networking." Abbott Molecular
    • "I continue to be impressed by the quality of speakers and depth of content at each marcus evans event.” AstraZeneca
    Join the Discussion

    Follow on LinkedIn